Artículos de revistas
High performance liquid chromatography analysis of a 4-anilinoquinazoline derivative (PD153035), a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in rat plasma
Registro en:
Journal Of Chromatography B-analytical Technologies In The Biomedical And Life Sciences. Elsevier Science Bv, v. 817, n. 2, n. 297, n. 302, 2005.
1570-0232
WOS:000226957700022
10.1016/j.jchromb.2004.12.021
Autor
Rocco, SA
Velho, JA
Marin, RM
Rolim, LD
Vercesi, AE
Rittner, R
Franchini, KG
Institución
Resumen
The quinazoline derivative, 4-N-(3'-bromo-phenyl)amino-6,7-dimethoxyquinazoline (PD153035), has recently been identified as a potential drug for the treatment of proliferative disease. Here, we report a sensitive high performance liquid chromatography (HPLC)-based quantitative detection method for measurement of PD153035 levels in rat plasma. Sample pretreatment involved a two-step extraction with chloroform. The analytes were separated on a column packed with OmniSpher C18 material and eluted with acetonitrile-0.1 M ammonium acetate, pH 7.2 (70:30, v/v). The column effluent was monitored by UV detection at 330 nm. A linear response was achieved over the concentration range 0.50-100.00 muM using multilevel calibration with an internal standard. The analytical method inter- and intra-run accuracy and precision were better than +/-15%. The lower limit of quantification was 0.50 muM. The method has been applied to study the preclinical pharmacokinetics of this compound in rats. (C) 2004 Elsevier B.V. All rights reserved. 817 2 297 302